Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Lange, Christopher P E ^a,b   Campan, Mihaela ^c   Hinoue, Toshinori ^d   Schmitz, Roderick F ^a   van der Meulen de Jong, Andrea E ^b   Slingerland, Hilde ^b   Kok, Peter J M J ^a   van Dijk, Cornelis M ^a   Weisenberger, Daniel J ^d   Shen, Hui ^d   Tollenaar, Robertus A E M ^b   Laird, Peter W ^c,d  

^a GROENE HART HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GENOMIC DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; C9ORF50 GENE; CANCER DIAGNOSIS; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; DNA PROBE; FEMALE; GENE; GENETIC MARKER; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; THBD M GENE; VALIDATION PROCESS;

ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA; DNA METHYLATION; FEMALE; GENETIC MARKERS; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84870326702     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050266     Document Type: Article

References (46)

1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (eds) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
2. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, et al. (2003) Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. European journal of cancer 39: 718-727.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: a cancer journal for clinicians 61: 69-90.
4. Winawer S, Fletcher R, Rex D, Bond J, Burt R, et al. (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124: 544-560.
5. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW, (2010) Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA: a cancer journal for clinicians 60: 99-119.
6. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 14: 2843-2877.
7. Laird PW, (2010) Principles and challenges of genomewide DNA methylation analysis. Nature reviews Genetics 11: 191-203.
8. Jones PA, Laird PW, (1999) Cancer epigenetics comes of age. Nature genetics 21: 163-167.
9. Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD, (2001) Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer research 61: 900-902.
10. Leung WK, To KF, Man EP, Chan MW, Bai AH, et al. (2005) Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. The American journal of gastroenterology 100 (10):: 2274-2279.
11. Nakayama H, Hibi K, Takase T, Yamazaki T, Kasai Y, et al. (2003) Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. International journal of cancer Journal international du cancer 105: 491-493.
12. Zou HZ, Yu BM, Wang ZW, Sun JY, Cang H, et al. (2002) Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clinical cancer research: an official journal of the American Association for Cancer Research 8: 188-191.
13. Muller HM, Widschwendter M, (2003) Methylated DNA as a possible screening marker for neoplastic disease in several body fluids. Expert Rev Mol Diagn 3: 443-458.
14. Devos T, Tetzner R, Model F, Weiss G, Schuster M, et al. (2009) Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer. Clinical chemistry 30: 30.
15. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, et al. (2008) DNA methylation biomarkers for blood-based colorectal cancer screening. Clinical chemistry 54 (2):: 414-423.
16. Wallner M, Herbst A, Behrens A, Crispin A, Stieber P, et al. (2006) Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 12: 7347-7352.
17. Herbst A, Wallner M, Rahmig K, Stieber P, Crispin A, et al. (2009) Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence. European journal of gastroenterology & hepatology 21: 565-569.
18. Tang D, Liu J, Wang DR, Yu HF, Li YK, et al. (2011) Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer. Clinical and investigative medicine Medecine clinique et experimentale 34: E88-95.
19. Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, et al. (2011) Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. The American journal of gastroenterology 106: 1110-1118.
20. Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, et al. (2011) The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association.
21. Tanzer M, Balluff B, Distler J, Hale K, Leodolter A, et al. (2010) Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PloS one 5: e9061.
22. Li M, Chen WD, Papadopoulos N, Goodman SN, Bjerregaard NC, et al. (2009) Sensitive digital quantification of DNA methylation in clinical samples. Nature biotechnology 27: 858-863.
23. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, et al. (2006) High-throughput DNA methylation profiling using universal bead arrays. Genome research 16: 383-393.
24. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, et al. (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome research 22: 271-282.
25. Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, et al. (2011) Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PloS one 6: e28141.
26. Campan M, Weisenberger DJ, Trinh B, Laird PW, (2009) MethyLight. Methods Mol Biol 507: 325-337.
27. Trinh BN, Long TI, Laird PW, (2001) DNA methylation analysis by MethyLight technology. Methods 25: 456-462.
28. Campan M WD, Trinh B, Laird PW (2009) MethyLight. In: J T, editor. DNA Methylation: Methods and Protocols. Second ed: Humana Press. pp. 325-337.
29. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, et al. (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic acids research 33 (21):: 6823-6836.
30. Weisenberger DJ, Trinh BN, Campan M, Sharma S, Long TI, et al. (2008) DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic acids research 36: 4689-4698.
31. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC bioinformatics 12: 77.
32. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
33. Shin CM, Kim N, Jung Y, Park JH, Kang GH, et al. (2010) Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis. Cancer science 101: 1337-1346.
34. To EW, Chan KC, Leung SF, Chan LY, To KF, et al. (2003) Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research 9: 3254-3259.
35. Fleischhacker M, Schmidt B, (2007) Circulating nucleic acids (CNAs) and cancer-a survey. Biochimica et biophysica acta 1775: 181-232.
36. Schwarzenbach H, Hoon DS, Pantel K, (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nature reviews Cancer 11: 426-437.
37. Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, et al. (2011) Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC medicine 9: 133.
38. Hughes Carvalho R, Haberle V, Hou J, van Gent T, Thongjuea S, et al. (2012) Genome-wide DNA methylation profiling of non-small cell lung carcinomas. Epigenetics & chromatin 5: 9.
39. Connolly D, Yang Z, Castaldi M, Simmons N, Oktay MH, et al. (2011) Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast cancer research: BCR 13: R76.
40. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, et al. (2008) Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer research 68: 4494-4499.
41. Bennett KL, Lee W, Lamarre E, Zhang X, Seth R, et al. (2010) HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes, chromosomes & cancer 49: 319-326.
42. Umetani N, Hiramatsu S, Hoon DS, (2006) Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Annals of the New York Academy of Sciences 1075: 299-307.
43. The Cancer Genome Atlas Research Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
44. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, et al. (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61: 847-854.
45. O'Connell JB, Maggard MA, Ko CY, (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. Journal of the National Cancer Institute 96: 1420-1425.
46. Kievit J, (2002) Follow-up of patients with colorectal cancer: numbers needed to test and treat. European journal of cancer 38: 986-999.